Albumin activates ERK via EGF receptor in human renal epithelial cells

Journal of the American Society of Nephrology

Volumn 16, Issue 5, 2005, Pages 1266-1278

  Reich, Heather ^a,d   Tritchler, David ^b   Herzenberg, Andrew M ^a   Kassiri, Zamaneh ^b   Zhou, Xiaohua ^c   Gao, Wei ^c   Scholey, James W ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b PRINCESS MARGARET HOSPITAL   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 4 (3 CHLOROANILINO) 6,7 DIMETHOXYQUINAZOLINE; ALBUMIN; EPIDERMAL GROWTH FACTOR RECEPTOR; INTERLEUKIN 8; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; REACTIVE OXYGEN METABOLITE; ALBUMINOID;

ARTICLE; CONTROLLED STUDY; DNA MICROARRAY; DRUG EFFECT; ENZYME ACTIVATION; GENE CONTROL; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; KIDNEY DISEASE; KIDNEY EPITHELIUM; POSITIVE FEEDBACK; PRIORITY JOURNAL; PROTEINURIA; SIGNAL TRANSDUCTION; UPREGULATION; CELL CULTURE; CYTOLOGY; EPITHELIUM CELL; GENE EXPRESSION REGULATION; GENETICS; KIDNEY; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY;

ALBUMINS; CELLS, CULTURED; EPITHELIAL CELLS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-8; KIDNEY; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; PHOSPHORYLATION; REACTIVE OXYGEN SPECIES; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION;

EID: 23944506156     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2004030222     Document Type: Article

References (56)

1. Remuzzi G, Bertani T: Is glomerulosclerosis a consequence of altered glomerular permeability to macromolecules? Kidney Int 38: 384-394, 1990
2. Cameron JS: Proteinuria and progression in human glomerular diseases. Am J Nephrol 10[Suppl 1]: 81-87, 1990
3. Ruggenenti P, Perna A, Mosconi L, Pisoni R, Remuzzi G: Urinary protein excretion rate is the best independent predictor of ESRF in non-diabetic proteinuric chronic nephropathies. "Gruppo Italiano di Studi Epidemiologici in Nefrologia" (GISEN). Kidney Int 53: 1209-1216, 1998
4. Remuzzi G, Bertani T: Pathophysiology of progressive nephropathies. N Engl J Med 339: 1448-1456, 1998
5. Eddy AA: Interstitial nephritis induced by protein-overload proteinuria. Am J Pathol 135: 719-733, 1989
6. Eddy AA, Giachelli CM: Renal expression of genes that promote interstitial inflammation and fibrosis in rats with protein-overload proteinuria. Kidney Int 47: 1546-1557, 1995
7. Abbate M, Zoja C, Corna D, Capitanio M, Bertani T, Remuzzi G: In progressive nephropathies, overload of tubular cells with filtered proteins translates glomerular permeability dysfunction into cellular signals of interstitial inflammation. J Am Soc Nephrol 9: 1213-1224, 1998
8. Gomez-Garre D, Largo R, Tejera N, Fortes J, Manzarbeitia F, Egido J: Activation of NF-kappaB in tubular epithelial cells of rats with intense proteinuria: Role of angiotensin II and endothelin-1. Hypertension 37: 1171-1178, 2001
9. Zoja C, Corna D, Camozzi D, Cattaneo D, Rottoli D, Batani C, Zanchi C, Abbate M, Remuzzi G: How to fully protect the kidney in a severe model of progressive nephropathy: A multidrug approach. J Am Soc Nephrol 13: 2898-2908, 2002
10. Wang Y, Chen J, Chen L, Tay YC, Rangan GK, Harris DC: Induction of monocyte chemoattractant protein-1 in proximal tubule cells by urinary protein. J Am Soc Nephrol 8: 1537-1545, 1997
11. Zoja C, Donadelli R, Colleoni S, Figliuzzi M, Bonazzola S, Morigi M, Remuzzi G: Protein overload stimulates RANTES production by proximal tubular cells depending on NF-kappaB activation. Kidney Int 53: 1608-1615, 1998
12. Mezzano SA, Barria M, Droguett MA, Burgos ME, Ardiles LG, Flores C, Egido J: Tubular NF-kappaB and AP-1 activation in human proteinuric renal disease. Kidney Int 60: 1366-1377, 2001
13. Tang S, Leung JC, Abe K, Chan KW, Chan LY, Chan TM, Lai KN: Albumin stimulates interleukin-8 expression in proximal tubular epithelial cells in vitro and in vivo. J Clin Invest 111: 515-527, 2003
14. Morigi M, Macconi D, Zoja C, Donadelli R, Buelli S, Zanchi C, Ghilardi M, Remuzzi G: Protein overload-induced NF-kappaB activation in proximal tubular cells requires H(2)O(2) through a PKC-dependent pathway. J Am Soc Nephrol 13: 1179-1189, 2002
15. Dixon R, Brunskill NJ: Albumin stimulates p44/p42 extracellular-signal- regulated mitogen-activated protein kinase in opossum kidney proximal tubular cells. Clin Sci (Lond) 98: 295-301, 2000
16. Takaya K, Koya D, Isono M, Sugimoto T, Sugaya T, Kashiwagi A, Haneda M: Involvement of ERK pathway in albumin-induced MCP-1 expression in mouse proximal tubular cells. Am J Physiol Renal Physiol 284: F1037-F1045, 2003
17. Tian W, Zhang Z, Cohen DM: MAPK signaling and the kidney. Am J Physiol Renal Physiol 279: F593-F604, 2000
18. Gautier L, Cope L, Bolstad BM, Irizarry RA: Affy-analysis of Affymetrix GeneChip data at the probe level. Bioinformatics 20: 307-315, 2004
19. Gentleman, Rossini Dudoit and Hornik. The Bioconductor FAQ. http://www.bioconductor.org/. Accessed September 2003.
20. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, Speed TP: Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4: 249-264, 2003
21. Irizarry R, Gautier L, Cope L: An R package for analyses of affymetrix oligonucleotide arrays. In: The Analysis of Gene Expression Data: Methods and Software, edited by Parmigiani G, Garett E, Irizarry R, Zeger S, New York, Springer, 2003, pp. 102-119
22. Tusher VG, Tibshirani R, Chu G: Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 98: 5116-5121, 2001
23. Marais R, Wynne J, Treisman R: The SRF accessory protein Elk-1 contains a growth factor-regulated transcriptional activation domain. Cell 73: 381-393, 1993
24. Kortenjann M, Thomae O, Shaw PE: Inhibition of v-raf-dependent c-fos expression and transformation by a kinase-defective mutant of the mitogen-activated protein kinase Erk2. Mol Cell Biol 14: 4815-4824, 1994
25. Hill CS, Treisman R: Transcriptional regulation by extracellular signals: Mechanisms and specificity. Cell 80: 199-211, 1995
26. Ushio-Fukai M, Griendling KK, Becker PL, Hilenski L, Halleran S, Alexander RW: Epidermal growth factor receptor transactivation by angiotensin II requires reactive oxygen species in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 21: 489-495, 2001
27. Rao GN: Protein tyrosine kinase activity is required for oxidant-induced extracellular signal-regulated protein kinase activation and c-fos and c-jun expression. Cell Signal 9: 181-187, 1997
28. Frank GD, Eguchi S, Yamakawa T, Tanaka S, Inagami T, Motley ED: Involvement of reactive oxygen species in the activation of tyrosine kinase and extracellular signal-regulated kinase by angiotensin II. Endocrinology 141: 3120-3126, 2000
29. Peterson JC, Adler S, Burkart JM, Greene T, Hebert LA, Hunsicker LG, King AJ, Klahr S, Massry SG, Seifter JL: Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study. Ann Intern Med 123: 754-762, 1995
30. Keane WF: Proteinuria: Its clinical importance and role in progressive renal disease. Am J Kidney Dis 35: S97-S105, 2000
31. Brenner BM, Goldszer RC, Hostetter TH: Glomerular response to renal injury. Contrib Nephrol 33: 48-66, 1982
32. Olson JL, Hostetter TH, Rennke HG, Brenner BM, Venkatachalam MA: Altered glomerular permselectivity and progressive sclerosis following extreme ablation of renal mass. Kidney Int 22: 112-126, 1982
33. Eddy AA: Proteinuria and interstitial injury. Nephrol Dial Transplant 19: 277-281, 2004
34. Zoja C, Benigni A, Remuzzi G: Cellular responses to protein overload: key event in renal disease progression. Curr Opinion Nephrol Hyp 13: 31-37, 2004
35. Sweeney WE Jr, Avner ED: Functional activity of epidermal growth factor receptors in autosomal recessive polycystic kidney disease. Am J Physiol 275: F387-F394, 1998
36. Torres VE, Sweeney WE Jr, Wang X, Qian Q, Harris PC, Frost P, Avner ED: EGF receptor tyrosine kinase inhibition attenuates the development of PKD in Han:SPRD rats. Kidney Int 64: 1573-1579, 2003
37. Levitzki A, Gazit A: Tyrosine kinase inhibition: An approach to drug development. Science 267: 1782-1788, 1995
38. Hobert M, Carlin C: Cytoplasmic juxtamembrane domain of the human EGF receptor is required for basolateral localization in MDCK cells. J Cell Physiol 162: 434-446, 1995
39. Amsler K, Kuwada SK: Membrane receptor location defines receptor interaction with signaling proteins in a polarized epithelium. Am J Physiol 276: C91-C101, 1999
40. Hobert ME, Friend LA, Carlin CR: Regulation of EGF signaling by cell polarity in MDCK kidney epithelial cells. J Cell Physiol 181: 330-341, 1999
41. Kuwada SK, Lund KA, Li XF, Cliften P, Amsler K, Opresko LK, Wiley HS: Differential signaling and regulation of apical vs. basolateral EGFR in polarized epithelial cells. Am J Physiol 275: C1419-C1428, 1998
42. Vermeer PD, Einwalter LA, Moninger TO, Rokhlina T, Kern JA, Zabner J, Welsh MJ: Segregation of receptor and ligand regulates activation of epithelial growth factor receptor. Nature 422: 322-326, 2003
43. Knebel A, Rahmsdorf HJ, Ullrich A, Herrlich P: Dephosphorylation of receptor tyrosine kinases as target of regulation by radiation, oxidants or alkylating agents. EMBO J 15: 5314-5325, 1996
44. Goldkorn T, Balaban N, Shannon M, Matsukuma K: EGF receptor phosphorylation is affected by ionizing radiation. Biochim Biophys Acta 1358: 289-299, 1997
45. Wetzker R, Bohmer FD: Transactivation joins multiple tracks to the ERK/MAPK cascade. Nat Rev Mol Cell Biol 4: 651-657, 2003
46. Daub H, Weiss FU, Wallasch C, Ullrich A: Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors. Nature 379: 557-560, 1996
47. Eguchi S, Numaguchi K, Iwasaki H, Matsumoto T, Yamakawa T, Utsunomiya H, Motley ED, Kawakatsu H, Owada KM, Hirata Y, Marumo F, Inagami T: Calcium-dependent epidermal growth factor receptor transactivation mediates the angiotensin II-induced mitogen-activated protein kinase activation in vascular smooth muscle cells. J Biol Chem 273: 8890-8896, 1998
48. Asakura M, Kitakaze M, Takashima S, Liao Y, Ishikura F, Yoshinaka T, Ohmoto H, Node K, Yoshino K, Ishiguro H, Asanuma H, Sanada S, Matsumura Y, Takeda H, Beppu S, Tada M, Hori M, Higashiyama S: Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: Metalloproteinase inhibitors as a new therapy. Nat Med 8: 35-40, 2002
49. Hua H, Munk S, Whiteside CI: Endothelin-1 activates mesangial cell ERK1/2 via EGF-receptor transactivation and caveolin-1 interaction. Am J Physiol Renal 284: F303-F312, 2003
50. Rhee SG, Bae YS, Lee SR, Kwon J: Hydrogen peroxide: A key messenger that modulates protein phosphorylation through cysteine oxidation. Sci STKE 2000: PE1, 2000
51. Touyz RM, Cruzado M, Tabet F, Yao G, Salomon S, Schiffrin EL: Redox-dependent MAP kinase signaling by Ang II in vascular smooth muscle cells: Role of receptor tyrosine kinase transactivation. Can J Physiol Pharmacol 81: 159-167, 2003
52. Mineo C, James GL, Smart EJ, Anderson RG: Localization of epidermal growth factor-stimulated Ras/Raf-1 interaction to caveolae membrane. J Biol Chem 271: 11930-11935, 1996
53. Lisanti MP, Scherer PE, Vidugiriene J, Tang Z, Hermanowski-Vosatka A, Tu YH, Cook RF, Sargiacomo M: Characterization of caveolin-rich membrane domains isolated from an endothelial-rich source: Implications for human disease. J Cell Biol 126: 111-126, 1994
54. Liu P, Ying Y, Ko YG, Anderson RG: Localization of platelet-derived growth factor-stimulated phosphorylation cascade to caveolae. J Biol Chem 271: 10299-10303, 1996
55. Mineo C, Ying YS, Chapline C, Jaken S, Anderson RG: Targeting of protein kinase Calpha to caveolae. J Cell Biol 141: 601-610, 1998
56. Zhougang S, Schnellmann RG: H2O2-induced transactivation of EGF receptor requires Src and mediates ERK1/2, but not Akt, activation in renal cells. Am J Physiol 286: F858-F865, 2004